TY - JOUR
T1 - Artificial Intelligence in Vascular-PET:
T2 - Translational and Clinical Applications
AU - Paravastu, Sriram S
AU - Theng, Elizabeth H
AU - Morris, Michael A
AU - Grayson, Peter
AU - Collins, Michael T
AU - Maass-Moreno, Roberto
AU - Piri, Reza
AU - Gerke, Oke
AU - Alavi, Abass
AU - Flemming Høilund-Carlsen, Poul
AU - Edenbrandt, Lars
AU - Saboury, Babak
N1 - Copyright © 2021 Elsevier Inc. All rights reserved.
PY - 2022/1
Y1 - 2022/1
N2 - Positron emission tomography (PET) offers an incredible wealth of diverse research applications in vascular disease, providing a depth of molecular, functional, structural, and spatial information. Despite this, vascular PET imaging has not yet assumed the same clinical use as vascular ultrasound, CT, and MR imaging which provides information about late-onset, structural tissue changes. The current clinical utility of PET relies heavily on visual inspection and suboptimal parameters such as SUVmax; emerging applications have begun to harness the tool of whole-body PET to better understand the disease. Even still, without automation, this is a time-consuming and variable process. This review summarizes PET applications in vascular disorders, highlights emerging AI methods, and discusses the unlocked potential of AI in the clinical space.
AB - Positron emission tomography (PET) offers an incredible wealth of diverse research applications in vascular disease, providing a depth of molecular, functional, structural, and spatial information. Despite this, vascular PET imaging has not yet assumed the same clinical use as vascular ultrasound, CT, and MR imaging which provides information about late-onset, structural tissue changes. The current clinical utility of PET relies heavily on visual inspection and suboptimal parameters such as SUVmax; emerging applications have begun to harness the tool of whole-body PET to better understand the disease. Even still, without automation, this is a time-consuming and variable process. This review summarizes PET applications in vascular disorders, highlights emerging AI methods, and discusses the unlocked potential of AI in the clinical space.
KW - Artificial Intelligence
KW - Humans
KW - Magnetic Resonance Imaging
KW - Positron-Emission Tomography
U2 - 10.1016/j.cpet.2021.09.003
DO - 10.1016/j.cpet.2021.09.003
M3 - Journal article
C2 - 34809874
VL - 17
SP - 95
EP - 113
JO - P E T Clinics
JF - P E T Clinics
SN - 1556-8598
IS - 1
ER -